鶹ý

Special Reports

Slippery Slope

More in Slippery Slope

Slippery Slope: A Targeted Therapy That Misses the Mark?

Afinitor racks up FDA approvals, but where is the evidence?

Dec 13, 2015
image
Slippery Slope: Does Convenience Trump Safety With NOACs?

Celebrities tout ease of new anticoagulants, but is there real benefit?

Aug 02, 2015
image
Slippery Slope: FDA Reviewer Questions Eliquis Mortality Claim

Trial data from more than 300 patients is missing

Aug 02, 2015
image
Slippery Slope: Diet Drugs No Help for Heart

In another edition of the Slippery Slope series examining use of surrogate endpoints in drug approvals, 鶹ý and the Milwaukee Journal Sentinel find diet drugs are approved without solid evidence of benefits, but with hints of harm.

Apr 19, 2015
image
Slippery Slope: $$ in, Diet Drugs Out, How Five Drugs Came to Market

Makers of diet drugs spent more than $60 million on payments to doctors, organized medicine, and lobbyists to get their drugs approved.

Apr 19, 2015
image
Slippery Slope: Fen-Phen Users Recall a 'Miracle' Turned Nightmare

Fen-phen use was linked to heart valve damage, as these two cases illustrate.

Apr 19, 2015
image